Invitae Corp. (NVTA)

18.08
0.34 1.85
NYSE : Health Services
Prev Close 18.42
Open 18.24
Day Low/High 18.00 / 18.57
52 Wk Low/High 7.08 / 26.77
Volume 219.68K
Avg Volume 2.05M
Exchange NYSE
Shares Outstanding 89.84M
Market Cap 1.62B
EPS -1.90
P/E Ratio N/A
Div & Yield N.A. (N.A)
Invitae And TME Research Announce Landmark New Study To Evaluate Universal Genetic Testing Of Breast Cancer Patients

Invitae And TME Research Announce Landmark New Study To Evaluate Universal Genetic Testing Of Breast Cancer Patients

Invitae Corporation (NYSE:NVTA), a genetic information company, and TME Research, LLC today announced the initiation of a new clinical collaboration to evaluate the benefits of universal genetic testing of...

Invitae Adds Two Genes, Offers Faster Turnaround Time For Its Breast Cancer STAT Panel

Invitae Adds Two Genes, Offers Faster Turnaround Time For Its Breast Cancer STAT Panel

Invitae Corporation (NYSE:NVTA), a genetic information company, today announced the expansion of its Breast Cancer STAT Panel with the addition of two important breast cancer predisposition genes - ATM and CHEK2...

Invitae To Present At The Canaccord Genuity Medical Technology & Diagnostics Forum

Invitae To Present At The Canaccord Genuity Medical Technology & Diagnostics Forum

Invitae Corporation (NYSE: NVTA), a genetic information company, today announced that members of the company's management team will present at the Canaccord Genuity Medical Technology & Diagnostics Forum on...

Invitae Announces Pricing Of Public Offering Of Common Stock

Invitae Announces Pricing Of Public Offering Of Common Stock

Invitae Corporation (NYSE:NVTA) today announced the pricing of an underwritten public offering of 7,333,333 shares of its common stock at a price to the public of $6.

Invitae Announces Proposed Public Offering Of Common Stock

Invitae Announces Proposed Public Offering Of Common Stock

Invitae Corporation (NYSE: NVTA) today announced that it has commenced an underwritten public offering of $40 million of shares of its common stock, before deducting underwriting discounts and commissions and other offering...

(Graphic: Invitae Corporation)

(Graphic: Invitae Corporation)

Invitae Corporation (NYSE: NVTA), a genetic information company, today announced financial and operating results for the third quarter ended September 30, 2016.

Invitae To Announce Third Quarter 2016 Financial Results And Host Conference Call On November 7, 2016

Invitae To Announce Third Quarter 2016 Financial Results And Host Conference Call On November 7, 2016

Invitae Corporation (NYSE: NVTA), a genetic information company, today announced that it will report its third quarter 2016 financial results on Monday, November 7, 2016 and will host a conference call that day at...

Invitae Announces Multiple Scientific Presentations And Posters To Be Presented At The American Society Of Human Genetics 2016 Annual Meeting

Invitae Announces Multiple Scientific Presentations And Posters To Be Presented At The American Society Of Human Genetics 2016 Annual Meeting

This week Invitae Corporation (NYSE: NVTA), a genetic information company, is presenting multiple abstracts at the American Society of Human Genetics (ASHG) 2016 Annual Meeting in Vancouver, covering an array of...

Invitae Announces Collaboration With Helix To Build Applications For Health And Wellness

Invitae Announces Collaboration With Helix To Build Applications For Health And Wellness

Invitae Corporation (NYSE: NVTA), a genetic information company, today announced a collaboration with Helix, a personal genomics company, to build novel, clinician-approved genetic testing applications designed to...

Invitae Announces Final Medicare Pricing Set At $925 For Hereditary Breast Cancer-Related Disorders Under New Billing Process

Invitae Announces Final Medicare Pricing Set At $925 For Hereditary Breast Cancer-Related Disorders Under New Billing Process

Invitae Corporation (NYSE: NVTA), a genetic information company, announced that the Centers for Medicare and Medicaid Services (CMS) announced final pricing for genetic testing for hereditary breast...

Genetic Counselors Recognized By Patients, Peers For Excellence In Patient Care

Genetic Counselors Recognized By Patients, Peers For Excellence In Patient Care

At the National Society of Genetic Counselors (NSGC) Annual Education Conference in Seattle, Allison Goetsch, MS, CGC, genetic counselor at Ann & Robert H.

Invitae Presenting Research On Genetic Test Panels, Increasing Access To Genetic Counseling At The National Society Of Genetic Counselors 35th Annual Education Conference

Invitae Presenting Research On Genetic Test Panels, Increasing Access To Genetic Counseling At The National Society Of Genetic Counselors 35th Annual Education Conference

This week Invitae Corporation (NYSE: NVTA), a genetic information company, is participating in the National Society of Genetic Counselors (NSGC) 35th Annual Education Conference in Seattle, highlighting new research...

5 Stocks Under $10 That Could Make You a Lot of Money

5 Stocks Under $10 That Could Make You a Lot of Money

These stocks trading for less than $10 a share are within range of triggering big breakout trades. Here's how to trade them from here.

Ratings Changes Today

TheStreet Quant Ratings provides fair and objective information to help you make educated investing decisions. We rate over 4,300 stocks daily and provide 5-page PDF reports for each stock. These ratings can change daily and today's changes are reflected in the email below. If you are looking to check-up on the stocks you currently own or are looking for new ideas, you can find our full database of password-protected ratings reports in our proprietary ratings screener: http://www.thestreet.com/k/qr/flat/stock-screener.html Upgrades: GPI, HMG, SGU Downgrades: NVTA, ORCL, VALU Initiations: S Read on to get TheStreet Quant Ratings' detailed report:

Invitae Announces Major Expansion Of Its Neurology And Cardiology Test Offerings

Invitae Announces Major Expansion Of Its Neurology And Cardiology Test Offerings

Invitae Corporation (NYSE: NVTA), a genetic information company, today announced that it has expanded its neurology and cardiology test offering, adding 11 new panels for heritable diseases.

Ratings Changes Today

TheStreet Quant Ratings provides fair and objective information to help you make educated investing decisions. We rate over 4,300 stocks daily and provide 5-page PDF reports for each stock. These ratings can change daily and today's changes are reflected in the email below. If you are looking to check-up on the stocks you currently own or are looking for new ideas, you can find our full database of password-protected ratings reports in our proprietary ratings screener: http://www.thestreet.com/k/qr/flat/stock-screener.html Upgrades: AVG, CIT, CRNT, CX, EGL, FOE, GOOD, ISNS, KRNT, KTEC, LBY, LPX, MIXT, MPC, MTSI, NATR, NVTA, REGN, SSTK Downgrades: CBPX, DVA, FCFP, ITG, PBH, STN Initiations: CFMS, JCAP, LILA, LILAK, NIHD, PYPL Read on to get TheStreet Quant Ratings' detailed report:

Invitae Announces Second Quarter 2016 Financial Results, Secures Contract With A National Payer And Expands Its Network Of Regional Private Payers

Invitae Announces Second Quarter 2016 Financial Results, Secures Contract With A National Payer And Expands Its Network Of Regional Private Payers

Invitae Corporation (NYSE: NVTA), a genetic information company, today announced financial and operating results for the second quarter ended June 30, 2016.

Invitae To Present At The Canaccord Genuity 36th Annual Growth Conference

Invitae To Present At The Canaccord Genuity 36th Annual Growth Conference

Invitae Corporation (NYSE:NVTA), a genetic information company, today announced that members of the company's management team will present at the Canaccord Genuity 36th Annual Growth Conference on Thursday, August...

Invitae To Announce Second Quarter 2016 Financial Results And Host Conference Call On August 8, 2016

Invitae To Announce Second Quarter 2016 Financial Results And Host Conference Call On August 8, 2016

Invitae Corporation (NYSE:NVTA), a genetic information company, today announced that it will report its second quarter 2016 financial results on Monday, August 8, 2016 and will host a conference call that day at...

Invitae Introduces New Breast Cancer STAT Panel For Patients With Breast Cancer Who Need Rapid Test Results To Guide Surgical Decisions

Invitae Introduces New Breast Cancer STAT Panel For Patients With Breast Cancer Who Need Rapid Test Results To Guide Surgical Decisions

Invitae Corporation (NYSE: NVTA), a genetic information company, today announced that the company now offers a new Breast Cancer STAT Panel of high-quality genetic testing designed for breast cancer patients whose...

Invitae Contributes More Than 10,000 Additional Genetic Variants To The ClinVar Project

Invitae Contributes More Than 10,000 Additional Genetic Variants To The ClinVar Project

Invitae Corporation (NYSE: NVTA), a genetic information company, today announced that the company has submitted information on more than 10,000 clinically observed genetic variants to the ClinVar project, an...

Invitae is Now Oversold (NVTA)

Invitae is Now Oversold (NVTA)

Legendary investor Warren Buffett advises to be fearful when others are greedy, and be greedy when others are fearful. One way we can try to measure the level of fear in a given stock is through a technical analysis indicator called the Relative Strength Index, or RSI, which measures momentum on a scale of zero to 100.

Veracyte Dips After CMS Proposes Reimbursement Rate Reduction

Veracyte Dips After CMS Proposes Reimbursement Rate Reduction

Shares of Veracyte are sliding after the Centers for Medicare and Medicaid Services, or CMS, proposed a reimbursement rate reduction on the company's Afirma GEC diagnostic test.

Invitae Announces The Launch Of CancerCHECK To Guide And Support Community Oncologists Through The Hereditary Cancer Genetic Testing Process

Invitae Announces The Launch Of CancerCHECK To Guide And Support Community Oncologists Through The Hereditary Cancer Genetic Testing Process

To help community oncologists more easily follow clinical guidelines on the use of genetic testing, Invitae Corporation (NYSE: NVTA), a genetic information company, today announced the availability of CancerCHECK...

Invitae Now Offers Comprehensive, High-Quality, Affordable Genetic Testing In New York For Hereditary Cancer, Cardiology, And Epilepsy

Invitae Now Offers Comprehensive, High-Quality, Affordable Genetic Testing In New York For Hereditary Cancer, Cardiology, And Epilepsy

Invitae Corporation (NYSE: NVTA), a genetic information company, today announced that the company has completed the comprehensive Clinical Laboratory Evaluation Program and received its clinical laboratory permit...

Ratings Changes Today

TheStreet Quant Ratings provides fair and objective information to help you make educated investing decisions. We rate over 4,300 stocks daily and provide 5-page PDF reports for each stock. These ratings can change daily and today's changes are reflected in the email below. If you are looking to check-up on the stocks you currently own or are looking for new ideas, you can find our full database of password-protected ratings reports in our proprietary ratings screener: http://www.thestreet.com/k/qr/flat/stock-screener.html Upgrades: ALN, BRC, CNBKA, EROS, FLO, GG, NEWM Downgrades: ACLS, CTL, EVC, GMT, HY, KORS, NVTA, PHM, PX, QADA, QADB Initiations: EPRS Read on to get TheStreet Quant Ratings' detailed report:

Invitae To Present At The UBS Global Healthcare Conference

Invitae To Present At The UBS Global Healthcare Conference

Invitae Corporation (NYSE: NVTA), a genetic information company, today announced that members of the company's management team will present at the UBS Global Healthcare Conference on Monday, May 23, 2016 at...

Invitae Announces First Quarter 2016 Financial Results

Invitae Announces First Quarter 2016 Financial Results

Invitae Corporation (NYSE: NVTA), a genetic information company, today announced financial and operating results for the first quarter ended March 31, 2016.

Invitae To Present At The Bank Of America Merrill Lynch 2016 Health Care Conference

Invitae To Present At The Bank Of America Merrill Lynch 2016 Health Care Conference

Invitae Corporation (NYSE: NVTA), a genetic information company, today announced that members of the company's management team will present at the Bank of America Merrill Lynch 2016 Health Care Conference on...

TheStreet Quant Rating: D (Sell)